elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Tricine
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Tricine
RIS
0.000
(Research Intensity Score)
Papers
59
Top papers
Dynamic Regulation of the Interfacial pH for Highly Reversible Aqueous Zinc Ion Batteries
2023 · 72 citations
Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer
2023 · 12 citations
SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe 99m Tc-HYNIC-H6F in Breast Cancer Mouse Models
2017 · 78 citations
99m Tc ‐ HYNIC PEGylated Peptide Probe Targeting HER2 ‐Expression in Breast Cancer
2025 · 3 citations
Radiosynthesis and Preclinical Evaluation of [99mTc]Tc-HYNIC-anti-TIGIT for Immuno-SPECT Imaging
2026
Newest papers
Radiosynthesis and Preclinical Evaluation of [99mTc]Tc-HYNIC-anti-TIGIT for Immuno-SPECT Imaging
2026
3PC-010 Optimising 99MTC-hynic-psma labelling to achieve a homogeneous isoform profile: a step toward a standardised kit-based formulation
2026
Radiolabeling of Trastuzumab With Technetium‐99m [99mTc] as a Radioligand for Screening Mentha pulegium on HER‐2 Receptors
2026
99m Tc ‐ HYNIC PEGylated Peptide Probe Targeting HER2 ‐Expression in Breast Cancer
2025 · 3 citations
Synthesis and Preclinical Evaluation of 99 ᵐTc‐HYNIC–Finasteride: A Novel SPECT Radiotracer Targeting 5α‐Reductase in Prostate Cancer
2025 · 1 citations
A sample from the 59 top papers behind Tricine.
Create a free account to browse them all →
Tricine's history
Research intensity over time
Explore Tricine's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Tricine's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link